clinical trial · NCT06804603
A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use
ObesityTradipitantPlacebo
brief summary
The goal of this study is to measure the effects of using Tradipitant after GLP-1R agonist use on nausea and vomiting in healthy overweight, class I, or class II obese volunteers. The study is placebo-controlled with two treatment arms.
started
Feb 25, 2025
primary completion
Oct 6, 2025
completion
Oct 6, 2025
last updated
Nov 12, 2025
official title
A Proof of Concept, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight Class I or Class II Obese Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol